EPA and DHA Market Overview:
The EPA and DHA Market was valued at USD 1,670.04 Million in 2022. EPA and DHA market estimated to reach over USD 2,680.43 Million by 2030.and grow at a CAGR of 6.2% during the forecast period.
Growth drivers: Rising awareness of health benefits, increasing prevalence of chronic diseases, growing demand for preventive healthcare, and expanding applications in food, dietary supplements, and clinical nutrition.
Key regions: North America, Europe, and Asia Pacific are leading the market, with Asia Pacific expected to witness the fastest growth due to rising disposable incomes and growing health awareness.
Market Drivers:
Health benefits: EPA and DHA are associated with reducing the risk of cardiovascular diseases, cognitive decline, and inflammatory conditions.
Chronic disease prevalence: Rising cases of heart disease, diabetes, and other chronic conditions are driving EPA and DHA market demand for preventive measures, including EPA and DHA supplementation.
Preventive healthcare: Growing focus on proactive health management is increasing the adoption of EPA and DHA for overall well-being.
Expanding applications: The use of EPA and DHA is expanding beyond dietary supplements to include functional foods, infant formula, pet food, and pharmaceuticals.
Market Key Players:
KD Pharma Group, Corbion NV, Novasep Holding SAS, Neptune Wellness Solutions, BASF SE, Omega Protein Corporation, Croda International PLC, Novotech Nutraceuticals, Polaris SA, and AlgalR NutraPharms Pvt. Ltd
Market Segmentation:
The Veterinary Diagnostic Imaging Market segmentation based on various factors, including:
By Type: Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA)
By Source: Fish Oil, Algae Oil, Krill Oil, and Others
By Application: Infant Formula, Dietary Supplements, Fortified Food and Beverages, Pharmaceuticals, and Others
Regional Analysis
North America: A Mature Market with Steady Growth
Dominant force: The North American region currently holds the largest EPA and DHA Market Growth, driven by factors like high disposable income, growing health awareness, and established distribution channels.
Focus on preventive healthcare: Consumers are increasingly opting for EPA and DHA supplements as part of their preventive healthcare regimens, particularly for heart and brain health.
Key players: The market is dominated by established players like BASF, DSM, and Amway, alongside regional players like Cargill and Omega Nutrition.
Europe: Stringent Regulations and Rising Demand
Regulatory landscape: Stringent regulations governing food and dietary supplements in Europe present both challenges and opportunities for market players.
Growing demand for fortified foods: Consumers are increasingly seeking fortified food products enriched with EPA and DHA, particularly for infant formula and functional foods.
Key players: Leading players include BASF, DSM, and Lonza, with regional players like Aker BioMarine and Orkla Health also gaining traction.
Asia Pacific: A Booming Market with Diverse Drivers
Rapid economic growth: Rising disposable incomes and increasing awareness of health benefits are fueling market expansion in this region.
Focus on infant nutrition and brain development: The demand for EPA and DHA-fortified infant formula is surging, driven by concerns about child development.
Key players: International players like BASF and DSM are present alongside regional players like China Resources and BYD Pharma.
Contact us:
Consegic Business intelligence Pvt Ltd.
Contact no: (US) (505) 715-4344
Email: [email protected]
